|
⚲
|
| Keyboard |
| Sands Capital Global Venture Fund II LP
✚
|
|
|---|---|
| CIK # | 0001870493 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001870493] | |
| 4 | [0001870493] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sands Capital Ventures Discovery Fund III LP | |
| Sands Capital Life Sciences Pulse Fund LLC | |
| Sands Capital Global Venture Fund II LP | |
| Acumen Pharmaceuticals Inc | |
| Sands Frank M |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2021-07-06 | Conversion | 1,842,346 | ||
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2021-07-06 | Conversion | 1,124,729 | ||
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2021-07-06 | Buy | 450,000 | $14.88 | 6,696,000 |
|
Acumen Pharmaceuticals Inc ABOS
Series B Preferred Stock · derivative
|
2021-07-06 | Conversion | 1,842,346 | ||
|
Acumen Pharmaceuticals Inc ABOS
Series A-1 Preferred Stock · derivative
|
2021-07-06 | Conversion | 1,124,729 |